(Q42139482)

17 October 2017

Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial. (English)

1 reference

17 October 2017

1 reference

1 reference

Shuba Rajashri Iyengar

1

1 reference

17 October 2017

Elizabeth G Hoyte

2

1 reference

17 October 2017

Angelica Loza

3

1 reference

17 October 2017

Salvatore Bonaccorso

4

1 reference

17 October 2017

David Chiang

5

1 reference

17 October 2017

Dale T Umetsu

6

1 reference

17 October 2017

Kari Christine Nadeau

7

1 reference

17 October 2017

27 June 2013

1 reference

International Archives of Allergy and Immunology

17 October 2017

1 reference

17 October 2017

162

1 reference

17 October 2017

1

1 reference

17 October 2017

89-93

1 reference

IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Effects of omalizumab on markers of inflammation in patients with allergic asthma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Thymic stromal lymphopoietin: master switch for allergic inflammation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Omalizumab treatment downregulates dendritic cell FcepsilonRI expression

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

P-, E-, and L-selectin mediate migration of activated CD8+ T lymphocytes into inflamed skin.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Atopic eczema: its social and financial costs.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161454

Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000350486

Efficacy of Omalizumab therapy in a case of severe atopic dermatitis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000350486

Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000350486

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23816920

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23816920

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000350486

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

23816920

1 reference